Peripartum infectious morbidity in women with preeclampsia
- PMID: 31167579
- PMCID: PMC7219109
- DOI: 10.1080/14767058.2019.1628944
Peripartum infectious morbidity in women with preeclampsia
Abstract
Background: Dysregulated maternal systemic inflammatory response is a commonly accepted component in the pathogenesis of preeclampsia. Chronic inflammation then occurs characterized by oxidative stress, proinflammatory cytokine production, and abnormal T-cell function. Infection results in similar physiologic changes.
Objective: The objective of this study was to examine the association between the diagnosis of preeclampsia and the development of chorioamnionitis, postpartum fever, endometritis and wound infection. We hypothesize that the heightened chronic inflammatory state of preeclampsia increases the risk for maternal peripartum infection.
Study design: This was a retrospective cohort study from the Consortium on Safe Labor (CSL). In the present analysis, we included all women from the CSL database and compared their characteristics and pregnancy outcomes between those with and without a diagnosis of preeclampsia prior to labor. Women presenting with preterm prelabor rupture of membranes or were diagnosed with preeclampsia during labor or postpartum were excluded. The primary outcome was a composite of maternal peripartum infections including intrapartum chorioamnionitis, postpartum fever, endometritis, and wound infection. This outcome was compared between women with and without a diagnosis of preeclampsia prior to labor using univariable and multivariable analyses.
Results: A total of 227,052 women were eligible for the analysis, of these 14,268 (6.3%) were diagnosed with preeclampsia. In univariable analysis, the rate of composite maternal peripartum infection was higher among women with preeclampsia (4.2 versus 3.8%, p = .026). When looking at each individual component, that rates of wound infection (1.0 versus 0.5%, p < .001) and postpartum fever (8.2 versus 4.4%, p < .001) were higher among women with diagnosis of preeclampsia, whereas the rate of intrapartum chorioamnionitis was lower among women with preeclampsia (1.3 versus 1.7% p = .004). Endometritis rates did not differ between the two groups. In multivariable logistic regression, adjusted for confounding variables, including maternal race, insurance status, prepregnancy BMI, maternal age, number of fetuses, number of vaginal exams, intrauterine pressure catheter and fetal scalp electrode placement, mode of delivery, group B streptococcus positivity, maternal education level, induction of labor, prelabor rupture of membranes, tobacco use, presence of diabetes (pregestational and gestational), gestational age at delivery, and chronic hypertension, the association between preeclampsia and composite maternal peripartum infection did not persist. In fact, after controlling for these influences, women with preeclampsia showed lower rates of intrapartum chorioamnionitis (aOR 0.83, 95% CI 0.70-0.99). The rest of the individual component of the primary composite outcome, postpartum fever, endometritis, and wound infection, were not associated with the diagnosis of preeclampsia.
Conclusions: In this large cohort of women diagnosed with preeclampsia prior to labor, the rate of intrapartum chorioamnionitis was decreased and the rate of postpartum infectious morbidity was not higher compared to women without a diagnosis of preeclampsia.
Keywords: Preeclampsia; chorioamnionitis; endometritis; inflammation; peripartum infection; wound infection.
Conflict of interest statement
The authors did not report any potential conflict of interest.
Similar articles
-
Is Group B Streptococcus Colonization Associated with Maternal Peripartum Infection in an Era of Routine Prophylaxis?Am J Perinatol. 2021 Aug;38(S 01):e262-e268. doi: 10.1055/s-0040-1709666. Epub 2020 May 23. Am J Perinatol. 2021. PMID: 32446262
-
Ampicillin and gentamicin prophylaxis is superior to ampicillin alone in patients with prelabor rupture of membranes at term: the results of a randomized clinical trial.Am J Obstet Gynecol. 2025 Mar 12:S0002-9378(25)00156-5. doi: 10.1016/j.ajog.2025.03.011. Online ahead of print. Am J Obstet Gynecol. 2025. PMID: 40086563
-
Antibiotic treatment of women with isolated intrapartum fever vs clinical chorioamnionitis: maternal and neonatal outcomes.Am J Obstet Gynecol. 2023 Nov;229(5):540.e1-540.e9. doi: 10.1016/j.ajog.2023.05.013. Epub 2023 Jul 4. Am J Obstet Gynecol. 2023. PMID: 38051599
-
Infectious morbidity of speculum versus digital examinations in preterm prelabor rupture of membranes: a systematic review and meta-analysis.J Matern Fetal Neonatal Med. 2022 Dec;35(25):8905-8911. doi: 10.1080/14767058.2021.2006628. Epub 2021 Nov 24. J Matern Fetal Neonatal Med. 2022. PMID: 34818968
-
Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections.Cochrane Database Syst Rev. 2020 Apr 26;4(4):CD007892. doi: 10.1002/14651858.CD007892.pub7. Cochrane Database Syst Rev. 2020. PMID: 32335895 Free PMC article.
Cited by
-
Factors influencing health promotion behavior on puerperal sepsis among postpartum mothers.BMC Pregnancy Childbirth. 2025 Mar 11;25(1):273. doi: 10.1186/s12884-025-07275-y. BMC Pregnancy Childbirth. 2025. PMID: 40069706 Free PMC article.
-
Retrospective study of intrapartum fever in term pregnancies and adverse obstetric and neonatal outcomes.PeerJ. 2022 Oct 27;10:e14242. doi: 10.7717/peerj.14242. eCollection 2022. PeerJ. 2022. PMID: 36320562 Free PMC article.
References
-
- ACOG Committee on Practice Bulletins. Practice bulletin #202: Gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133:e1–e25. - PubMed
-
- Creasy RK, Resnik R, Iams JD, Lockwood CJ, Moore T, Greene MF. Creasy and Resnik’s Maternal-Fetal Medicine: Principles and Practice. Elsevier Health Sciences; 2013.
-
- Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel JP, et al. WHO Multicountry Survey on Maternal and Newborn Health Research Network. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG-Int Obstet Gy. 2014;121:14–24. - PubMed
-
- Souza JP, Gülmezoglu AM, Vogel J, Carroli G, Lumbiganon P, Qureshi Z, et al. Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study. Lancet. 2013;381:1747–55. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources